Rotigotine – New Option for Advanced Parkinson’s Disease

I am excited to see that a new medication for Parkinson’s Disease is added to the Ontario Drug Benefits formulary. Neupro (rotigotine) is a dopamine agonist formulated as a transdermal patch and is indicated for both early and advanced stages of Parkinson’s disease as well as restless leg syndrome.

Continue reading Rotigotine – New Option for Advanced Parkinson’s Disease

Advertisements

New Treatments in Parkinson’s Disease

April is Parkinson’s Awareness Month.  Last year, I wrote a post about common issues faced by individuals affected by Parkinson’s disease. This year, I want to focus on new treatments that are already available or soon coming down the pipeline.

Continue reading New Treatments in Parkinson’s Disease

It’s Parkinson’s Disease but you don’t have to freeze.

Parkinson’s disease is a neuro-degenerative disorder with progressive loss of dopaminergic neurons in the substantia nigra, the region of the brain that deals with movement, muscle control and balance. Continue reading It’s Parkinson’s Disease but you don’t have to freeze.